US equities Value stocks: A dynamic approach in a changing world

 Invesco logo
Invesco Opens in a new tab
Night city skyline with river and colorful light trails reflecting between tall buildings

Key takeaways

  • Value managers rely on historical valuations, but projecting what the future may look like is also critical when investing in a rapidly changing world.

  • Price-to-book isn’t the only way to measure a stock’s value. A dynamic approach that uses various metrics can help a portfolio stand the test of time.

  • Health care stocks have become inexpensive. Buying high quality health care companies with a 3- to 5-year time horizon may be a meaningful opportunity for value investors.

Not only do active value managers have to navigate rate volatility, macro uncertainty, and technological disruptions, they also have to determine the difference between undervalued opportunities and the dreaded value trap. Kevin Holt, Chief Investment Officer and Senior Portfolio Manager for Invesco's US Value Equity Team, joined the latest episode of the Greater Possibilities podcast to explain how he approaches the challenge of value investing in a changing world.

Listen to the full conversation with Kevin and read the highlights below.

Rethink Portfolios: US value stocks with Kevin Holt

00:00
00:00
00:00
Listen

Host Danielle Singer sits down with Kevin Holt for a timely, in-depth conversation on US value equities.

Highlights from the conversation

Managing through complexity

“Intellectual honesty is something I think that we all need to be very aware of. And the reality is, whether it's volatility and/or the proliferation of AI, the world is changing. And in value land, we all like to look at historical valuations, historical attributes … Our investment process does not change, but we have to realize if the cash flows are going to change based on changing fundamentals, we need to be out in front of that. We always say it's where the puck's going, not where it's been. In my role as CIO, I always say I'm an air traffic controller, trying to make sure that all the teams are looking at what the future looks like, not just what the past looks like.”

Value is more than one metric

“I think when people look at the Russell 1000 Value, it has a very high reliance on price-to-book value in terms of its constitution. And we would argue outside of deep cyclicals and/or banks, price-to-book really doesn't have a role historically in defining value across different industries and sectors … So you need to make sure that you have a dynamic process that basically works through the test of time when you're approaching investing. And if anyone has any single metric, they'll probably be good for short periods of time … If you're a price-to-book investor, when financials work or when you go into an upturn, they work. We want to be able to work overall cycles.”

Opportunities in health care

“Things that particularly look interesting right now for us is health care. … I think a lot of investors who look for innovation used to look at health care and technology. I think a lot of those dollars have gone to technology recently, so health care has become very inexpensive.1 … When you can buy the highest quality companies in industry groups across health care, which is frankly what we're in the midst of right now, I think that's very attractive when we have a time arbitrage, 3- to 5-year time horizon on our side. And these are very attractive businesses with very attractive cash flows and very attractive return on invested capital profiles.”

Distinguishing the difference between mispriced companies and value traps

“When a stock is selling at a discounted valuation relative to history, it's up to us as fundamental investors to determine what are those three or four key issues that investors are concerned about on a 3- to 5-year time horizon and why is this selling at a discounted valuation? So it's really understanding the fundamentals of the business and understanding why it's trading like it is that I think ultimately leads you in the direction of being able to identify value traps.”

Taking a look at technology

“There are always pockets in technology that don't necessarily generate cash flow. but they're very conceptually interesting. A couple stocks historically just have not fit our process and probably never will … With that said, I think 90% of the technology stocks periodically do hit our radar. And as we predict things out and project cash flows, I think they can be interesting.”

  • 1

    Discussions about the relative value of the health care sector versus the broad US market is based on comparisons of the S&P 500 Index and the S&P 500 Health Care sector from 1979 through 2025, sourced from Worldscope, IBES, and GMO.

Fresh insights, delivered

Get the latest information and insights from our portfolio managers, market strategists, and investment experts.  

Fresh insights, delivered
Topic preference

When you interact with us, we may collect information about you which constitutes personal data under applicable laws and regulations. Our privacy notice explains how we use and protect your personal data.